Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Plasminogen Eye Drops Are Effective in Preventing Recurrence of Pseudomembranes in Ligneous Conjunctivitis: Results from the Phase 2/3 KB046 Trial

Roberto Caputo, MD, Maria Teresa Sartori, MD, Andrea Leonardi, MD, Anna Lotti Suffredini, BSc (Bio), Mirella Calcinai, MD, Roberto Crea, DVM, MSc, Prasad Mathew, MD, Charles Nakar, MD, Neelam Thukral, CCRC, Amy D Shapiro, MD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-137538

Published: 2020

Journal Articles

Reconstituted Bay 81-8973 Factor VIII Stability Supports Its Suitability for Continuous Infusion for up to 24 Hours

John M. Teare, PhD, Jared Trefethen, Stephen Garger, Prasad Mathew, MD

Blood (2018) 132 (Supplement 1): 5043.

https://doi.org/10.1182/blood-2018-99-114976

Published: 2018

Journal Articles

Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children’s Oncology Group AAML0431 trial

Jeffrey W. Taub, Jason N. Berman, Johann K. Hitzler, April D. Sorrell, Norman J. Lacayo, Kelley Mast, David Head, Susana Raimondi, Betsy Hirsch, Yubin Ge, Robert B. Gerbing, Yi-Cheng Wang, Todd A. Alonzo, Dario Campana, Elaine Coustan-Smith, Prasad Mathew, Alan S. Gamis

Blood (2017) 129 (25): 3304–3313.

https://doi.org/10.1182/blood-2017-01-764324

Published: 2017

Includes: Supplemental data

Journal Articles

Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls

Natasha Amrita Satkunam, MBBS, MSc, Johnny Mahlangu, MD, Christoph Bidlingmaier, MD PD, Dr. MD, Maria Eva Mingot-Castellano, PhD, Meera B. Chitlur, MD, Patrick F. Fogarty, MD, Adam Cuker, MD MS, Maria Elisa Mancuso, MD PhD, Pal André Holme, PhD MD, Julie Grabell, BA, CCRP, Wilma Hopman, MA, Prasad Mathew, MD, Paula D. James, MD

Blood (2016) 128 (22): 875.

https://doi.org/10.1182/blood.V128.22.875.875

Published: 2016

Journal Articles

Mapping T-Cell Peptide Epitopes on Activated Recombinant Factor VII (rFVIIa) Contributing to Inhibitor Antibody Response

Pedro Paz, Jens Schroeder, Prasad Mathew, Marion Hardtke, Fred Aswad

Blood (2015) 126 (23): 2295.

https://doi.org/10.1182/blood.V126.23.2295.2295

Published: 2015

Journal Articles

Improvement in Treatment Outcome and Identification of a New Prognostic Parameter in Down Syndrome Acute Myeloid Leukemia (DS-AML): Results of the Children’s Oncology Group (COG) Phase III AAML0431 Trial

Jeffrey W Taub, MD, Jason N Berman, MD, Johann K. Hitzler, MD, April D. Sorrell, MD, Norman J. Lacayo, MD, Kelley Mast, MD, David R. Head, MD, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Robert B. Gerbing, MA, Todd A. Alonzo, PhD, Dario Campana, MD PhD, Elaine Coustan-Smith, MS, Prasad Mathew, Alan S. Gamis, MD MPH

Blood (2014) 124 (21): 278.

https://doi.org/10.1182/blood.V124.21.278.278

Published: 2014

Journal Articles

SeveN BleeP Registry – 5 Years Later: An Update.

Jan Blatny, MD, PhD, Prasad Mathew, MD, John Puetz, MD, Petra Ovesna, PhD, Petr Brabec, PhD

Blood (2010) 116 (21): 3651.

https://doi.org/10.1182/blood.V116.21.3651.3651

Published: 2010

Journal Articles

Bioequivalence, Heat Stability and Reconstitution of Room Temperature Stable Recombinant Activated Factor VII (rFVIIa-RT)

Prasad Mathew, MD, Jens Bjerre, MD, David L. Cooper, MD, MBA

Blood (2008) 112 (11): 4083.

https://doi.org/10.1182/blood.V112.11.4083.4083

Published: 2008

Journal Articles

COG AAML03P1: Efficacy and Safety in a Pilot Study of Intensive Chemotherapy Including Gemtuzumab in Children Newly Diagnosed with Acute Myeloid Leukemia (AML)

Janet Franklin, MD, MPH, Todd Alonzo, PhD, Craig Alan Hurwitz, MD, Robert Gerbing, Franklin Smith, Robert J. Arceci, MD, PhD, James Feusner, MD, Prasad Mathew, MD, Robert Iannone, MD, Soheil Meshinchi, MD, PhD, Robert Lavey, MD, MPH, Joetta D Wallace, RN, Kelly Anderson, RN, Laura Winter, PharmD, Kathleen Glick, BA, Betty Hirsch, MD, Susana C. Raimondi, PhD, Alan Gamis, MD

Blood (2008) 112 (11): 136.

https://doi.org/10.1182/blood.V112.11.136.136

Published: 2008

Journal Articles

The Risk of Thrombotic Events in Neonates Treated with Recombinant Factor VIIa.

John Puetz, MD, Ginger Darling, MD, Petr Brabec, M.Sc., Jan Blatny, MD PhD, Prasad Mathew, MD

Blood (2007) 110 (11): 3193.

https://doi.org/10.1182/blood.V110.11.3193.3193

Published: 2007

Journal Articles

Correlates of Spontaneous Clearance of Hepatitis C Virus among HIV-Infected Persons with Hemophilia.

Barbara A. Konkle, MD, Lehida Melendez-Morales, M.P.H., Liliana Preiss, M.S., Mingdong Zhang, M.D., Ph.D., Prasad Mathew, M.D., M. Elaine Eyster, M.D., James J. Goedert, M.D.

Blood (2006) 108 (11): 1265.

https://doi.org/10.1182/blood.V108.11.1265.1265

Published: 2006

Journal Articles

An Open-Label, Randomized, Parallel, Multi-Center Trial Comparing the Safety and Efficacy of rFVIIa When Administered as I.V. Bolus or I.V. Continuous Infusion to Hemophilia Patients with Inhibitors during and after Surgery.

Rajiv K. Pruthi, MD, Prasad Mathew, MD, Leonard A. Valentino, MD, Stephanie V. Seremetis, MD

Blood (2004) 104 (11): 3975.

https://doi.org/10.1182/blood.V104.11.3975.3975

Published: 2004

Journal Articles

Detection of the t(2; 5)(p23; q35) and NPM-ALK Fusion in Non-Hodgkin's Lymphoma by Two-Color Fluorescence In Situ Hybridization

Prasad Mathew, Warren G. Sanger, Dennis D. Weisenburger, Marcus Valentine, Virginia Valentine, Diane Pickering, Chris Higgins, Michelle Hess, Xiaoli Cui, Deo Kumar Srivastava, Stephan W. Morris

Blood (1997) 89 (5): 1678–1685.

https://doi.org/10.1182/blood.V89.5.1678

Published: 1997

NARROW

Plasminogen Eye Drops Are Effective in Preventing Recurrence of Pseudomembranes in Ligneous Conjunctivitis: Results from the Phase 2/3 KB046 Trial

Reconstituted Bay 81-8973 Factor VIII Stability Supports Its Suitability for Continuous Infusion for up to 24 Hours

Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children’s Oncology Group AAML0431 trial

Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls

Mapping T-Cell Peptide Epitopes on Activated Recombinant Factor VII (rFVIIa) Contributing to Inhibitor Antibody Response

Improvement in Treatment Outcome and Identification of a New Prognostic Parameter in Down Syndrome Acute Myeloid Leukemia (DS-AML): Results of the Children’s Oncology Group (COG) Phase III AAML0431 Trial

SeveN BleeP Registry – 5 Years Later: An Update.

Bioequivalence, Heat Stability and Reconstitution of Room Temperature Stable Recombinant Activated Factor VII (rFVIIa-RT)

COG AAML03P1: Efficacy and Safety in a Pilot Study of Intensive Chemotherapy Including Gemtuzumab in Children Newly Diagnosed with Acute Myeloid Leukemia (AML)

The Risk of Thrombotic Events in Neonates Treated with Recombinant Factor VIIa.

Correlates of Spontaneous Clearance of Hepatitis C Virus among HIV-Infected Persons with Hemophilia.

An Open-Label, Randomized, Parallel, Multi-Center Trial Comparing the Safety and Efficacy of rFVIIa When Administered as I.V. Bolus or I.V. Continuous Infusion to Hemophilia Patients with Inhibitors during and after Surgery.

Detection of the t(2; 5)(p23; q35) and NPM-ALK Fusion in Non-Hodgkin's Lymphoma by Two-Color Fluorescence In Situ Hybridization

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only